Published in J Biol Chem on July 07, 1995
Antiviral actions of interferons. Clin Microbiol Rev (2001) 13.06
Targeted and armed oncolytic poxviruses: a novel multi-mechanistic therapeutic class for cancer. Nat Rev Cancer (2009) 3.06
Kinetic analysis of a complete poxvirus transcriptome reveals an immediate-early class of genes. Proc Natl Acad Sci U S A (2008) 2.43
Cytomegalovirus activates interferon immediate-early response gene expression and an interferon regulatory factor 3-containing interferon-stimulated response element-binding complex. Mol Cell Biol (1998) 2.39
The vaccinia virus soluble alpha/beta interferon (IFN) receptor binds to the cell surface and protects cells from the antiviral effects of IFN. J Virol (2000) 2.08
Impaired antiviral response and alpha/beta interferon induction in mice lacking beta interferon. J Virol (2000) 2.03
Blocking of the alpha interferon-induced Jak-Stat signaling pathway by Japanese encephalitis virus infection. J Virol (2004) 2.01
Defining Effective Combinations of Immune Checkpoint Blockade and Oncolytic Virotherapy. Clin Cancer Res (2015) 1.61
Vaccinia virus blocks gamma interferon signal transduction: viral VH1 phosphatase reverses Stat1 activation. J Virol (2001) 1.59
Synergistic interaction between oncolytic viruses augments tumor killing. Mol Ther (2010) 1.51
Modified vaccinia virus Ankara induces Toll-like receptor-independent type I interferon responses. J Virol (2007) 1.50
Oncolytic viruses: a new class of immunotherapy drugs. Nat Rev Drug Discov (2015) 1.47
The Epstein-Barr virus BARF1 gene encodes a novel, soluble colony-stimulating factor-1 receptor. J Virol (1998) 1.46
The purified myxoma virus gamma interferon receptor homolog M-T7 interacts with the heparin-binding domains of chemokines. J Virol (1997) 1.43
A mechanism for the inhibition of fever by a virus. Proc Natl Acad Sci U S A (1996) 1.39
Vaccinia virus-mediated inhibition of type I interferon responses is a multifactorial process involving the soluble type I interferon receptor B18 and intracellular components. J Virol (2008) 1.26
Vaccinia virus vectors with an inactivated gamma interferon receptor homolog gene (B8R) are attenuated In vivo without a concomitant reduction in immunogenicity. J Virol (2001) 1.21
Expression of secreted cytokine and chemokine inhibitors by ectromelia virus. J Virol (2000) 1.20
The orthopoxvirus type I IFN binding protein is essential for virulence and an effective target for vaccination. J Exp Med (2008) 1.19
Improved innate and adaptive immunostimulation by genetically modified HIV-1 protein expressing NYVAC vectors. PLoS One (2011) 1.16
Inhibition of interferons by ectromelia virus. J Virol (2002) 1.15
Genome-wide analysis of polymorphisms associated with cytokine responses in smallpox vaccine recipients. Hum Genet (2012) 1.15
Innate immune suppression enables frequent transfection with RNA encoding reprogramming proteins. PLoS One (2010) 1.13
A mouse model of lethal infection for evaluating prophylactics and therapeutics against Monkeypox virus. J Virol (2010) 1.12
Dendritic cells are preferentially targeted among hematolymphocytes by Modified Vaccinia Virus Ankara and play a key role in the induction of virus-specific T cell responses in vivo. BMC Immunol (2008) 1.12
Inhibition of type I and type III interferons by a secreted glycoprotein from Yaba-like disease virus. Proc Natl Acad Sci U S A (2007) 1.08
Monkeypox virus and insights into its immunomodulatory proteins. Immunol Rev (2008) 1.07
Induction of potent humoral and cell-mediated immune responses by attenuated vaccinia virus vectors with deleted serpin genes. J Virol (2004) 1.06
Treating tumors with a vaccinia virus expressing IFNβ illustrates the complex relationships between oncolytic ability and immunogenicity. Mol Ther (2011) 1.06
Inhibition of type 1 cytokine-mediated inflammation by a soluble CD30 homologue encoded by ectromelia (mousepox) virus. J Exp Med (2002) 1.05
Replication of modified vaccinia virus Ankara in primary chicken embryo fibroblasts requires expression of the interferon resistance gene E3L. J Virol (2003) 1.05
Improved NYVAC-based vaccine vectors. PLoS One (2011) 1.04
Genome comparison of a nonpathogenic myxoma virus field strain with its ancestor, the virulent Lausanne strain. J Virol (2008) 1.02
Coactivating signals for the hepatic lymphocyte gamma interferon response to Francisella tularensis. Infect Immun (2006) 1.00
Vaccinia virus blocks Stat1-dependent and Stat1-independent gene expression induced by type I and type II interferons. J Interferon Cytokine Res (2008) 0.99
Subversion of cytokine networks by virally encoded decoy receptors. Immunol Rev (2012) 0.98
MHC-I-restricted epitopes conserved among variola and other related orthopoxviruses are recognized by T cells 30 years after vaccination. Arch Virol (2008) 0.98
Removal of vaccinia virus genes that block interferon type I and II pathways improves adaptive and memory responses of the HIV/AIDS vaccine candidate NYVAC-C in mice. J Virol (2012) 0.98
Stunned silence: gene expression programs in human cells infected with monkeypox or vaccinia virus. PLoS One (2011) 0.98
Orf virus encodes a novel secreted protein inhibitor of granulocyte-macrophage colony-stimulating factor and interleukin-2. J Virol (2000) 0.97
Cowpox virus encodes a fifth member of the tumor necrosis factor receptor family: a soluble, secreted CD30 homologue. Proc Natl Acad Sci U S A (2002) 0.96
The polyoma virus T antigen interferes with interferon-inducible gene expression. Proc Natl Acad Sci U S A (1998) 0.96
Enhancement of vaccinia virus based oncolysis with histone deacetylase inhibitors. PLoS One (2010) 0.95
Herpes simplex virus-1 infection causes the secretion of a type I interferon-antagonizing protein and inhibits signaling at or before Jak-1 activation. Virology (2009) 0.95
M135R is a novel cell surface virulence factor of myxoma virus. J Virol (2006) 0.94
Genetic screen of a mutant poxvirus library identifies an ankyrin repeat protein involved in blocking induction of avian type I interferon. J Virol (2013) 0.94
Role of genes that modulate host immune responses in the immunogenicity and pathogenicity of vaccinia virus. J Virol (2005) 0.92
Inhibition of alpha interferon but not gamma interferon signal transduction by phorbol esters is mediated by a tyrosine phosphatase. Mol Cell Biol (1996) 0.91
Antibody inhibition of a viral type 1 interferon decoy receptor cures a viral disease by restoring interferon signaling in the liver. PLoS Pathog (2012) 0.91
Inhibition of type III interferon activity by orthopoxvirus immunomodulatory proteins. J Interferon Cytokine Res (2010) 0.91
Novel codon-optimized mini-intronic plasmid for efficient, inexpensive, and xeno-free induction of pluripotency. Sci Rep (2015) 0.90
IFN-α and lipopolysaccharide upregulate APOBEC3 mRNA through different signaling pathways. J Immunol (2012) 0.90
Gamma interferon-induced interferon regulatory factor 1-dependent antiviral response inhibits vaccinia virus replication in mouse but not human fibroblasts. J Virol (2009) 0.90
Vaccinia virus protein N2 is a nuclear IRF3 inhibitor that promotes virulence. J Gen Virol (2013) 0.90
Dengue virus infection differentially regulates endothelial barrier function over time through type I interferon effects. J Infect Dis (2009) 0.90
The current status and future directions of myxoma virus, a master in immune evasion. Vet Res (2011) 0.90
Genomic analysis of the vaccinia virus strain variants found in Dryvax vaccine. J Virol (2011) 0.89
Vaccinia virus infection of mature dendritic cells results in activation of virus-specific naïve CD8+ T cells: a potential mechanism for direct presentation. Virology (2006) 0.88
A mechanism for the inhibition of DNA-PK-mediated DNA sensing by a virus. PLoS Pathog (2013) 0.88
A method for the generation of ectromelia virus (ECTV) recombinants: in vivo analysis of ECTV vCD30 deletion mutants. PLoS One (2009) 0.87
Vaccinia virus protein K7 is a virulence factor that alters the acute immune response to infection. J Gen Virol (2013) 0.86
Plasmacytoid dendritic cells in the tumor microenvironment: immune targets for glioma therapeutics. Neoplasia (2012) 0.86
The highly virulent variola and monkeypox viruses express secreted inhibitors of type I interferon. FASEB J (2009) 0.86
Mechanisms of immune escape in viral hepatitis. Gut (1999) 0.84
Host-range restriction of vaccinia virus E3L deletion mutant can be overcome in vitro, but not in vivo, by expression of the influenza virus NS1 protein. PLoS One (2011) 0.82
Humoral immunity to smallpox vaccines and monkeypox virus challenge: proteomic assessment and clinical correlations. J Virol (2012) 0.82
Cowpox virus inhibits human dendritic cell immune function by nonlethal, nonproductive infection. Virology (2011) 0.81
Glycosaminoglycans mediate retention of the poxvirus type I interferon binding protein at the cell surface to locally block interferon antiviral responses. FASEB J (2011) 0.81
Recent technological updates and clinical applications of induced pluripotent stem cells. Korean J Intern Med (2014) 0.81
Genetic screen of a library of chimeric poxviruses identifies an ankyrin repeat protein involved in resistance to the avian type I interferon response. J Virol (2013) 0.80
Oncolytic virus therapy for cancer. Oncolytic Virother (2013) 0.78
Vaccinia virus, a promising new therapeutic agent for pancreatic cancer. Immunotherapy (2015) 0.78
Predicting the subcellular localization of viral proteins within a mammalian host cell. Virol J (2006) 0.78
Evaluating the orthopoxvirus type I interferon-binding molecule as a vaccine target in the vaccinia virus intranasal murine challenge model. Clin Vaccine Immunol (2010) 0.78
Expression of porcine fusion protein IRF7/3(5D) efficiently controls foot-and-mouth disease virus replication. J Virol (2014) 0.78
Human antibody responses to the polyclonal Dryvax vaccine for smallpox prevention can be distinguished from responses to the monoclonal replacement vaccine ACAM2000. Clin Vaccine Immunol (2014) 0.78
Incorporation of the B18R gene of vaccinia virus into an oncolytic herpes simplex virus improves antitumor activity. Mol Ther (2012) 0.77
Genetically Engineered Vaccinia Viruses As Agents for Cancer Treatment, Imaging, and Transgene Delivery. Front Oncol (2017) 0.76
Attenuated and replication-competent vaccinia virus strains M65 and M101 with distinct biology and immunogenicity as potential vaccine candidates against pathogens. J Virol (2013) 0.76
Replication of Human Norovirus RNA in Mammalian Cells Reveals Lack of Interferon Response. J Virol (2016) 0.76
Deletion of the K1L Gene Results in a Vaccinia Virus That Is Less Pathogenic Due to Muted Innate Immune Responses, yet Still Elicits Protective Immunity. J Virol (2017) 0.75
Viral Inhibition of the IFN-Induced JAK/STAT Signalling Pathway: Development of Live Attenuated Vaccines by Mutation of Viral-Encoded IFN-Antagonists. Vaccines (Basel) (2016) 0.75
Induction of indoleamine 2,3-dioxygenase by Borrelia burgdorferi in human immune cells correlates with pathogenic potential. J Leukoc Biol (2014) 0.75
Oncolytic viruses: now interviewing for the all-star game. Mol Ther (2010) 0.75
Vaccinia Virus Protein C6 Inhibits Type I IFN Signalling in the Nucleus and Binds to the Transactivation Domain of STAT2. PLoS Pathog (2016) 0.75
RNA-Seq Based Transcriptome Analysis of the Type I Interferon Host Response upon Vaccinia Virus Infection of Mouse Cells. J Immunol Res (2017) 0.75
Molecular and Structural Characterization of a Novel Escherichia coli Interleukin Receptor Mimic Protein. MBio (2016) 0.75
Insertion of the Type-I IFN Decoy Receptor B18R in a miRNA-Tagged Semliki Forest Virus Improves Oncolytic Capacity but Results in Neurotoxicity. Mol Ther Oncolytics (2017) 0.75
Inhibition of viral replication by interferon-gamma-induced nitric oxide synthase. Science (1993) 4.80
Tyrosine phosphorylation of DNA binding proteins by multiple cytokines. Science (1993) 3.78
Herpes simplex virus types 1 and 2 completely help adenovirus-associated virus replication. J Virol (1981) 3.72
Decreased virulence of recombinant vaccinia virus expression vectors is associated with a thymidine kinase-negative phenotype. Nature (1985) 3.62
Interferon-stimulated transcription: isolation of an inducible gene and identification of its regulatory region. Proc Natl Acad Sci U S A (1986) 2.92
Helminth infection results in decreased virus-specific CD8+ cytotoxic T-cell and Th1 cytokine responses as well as delayed virus clearance. Proc Natl Acad Sci U S A (1993) 2.65
Induction of cytotoxic T-cell responses in vivo in the absence of CD4 helper cells. Nature (1987) 2.45
Characterization of adenovirus-associated virus-induced polypeptides in KB cells. J Virol (1978) 2.40
Different roles for CD4+ and CD8+ T lymphocytes and macrophage subsets in the control of a generalized virus infection. J Virol (1996) 2.32
Vaccinia and cowpox viruses encode a novel secreted interleukin-1-binding protein. Cell (1992) 2.19
Importance of interferons in recovery from mousepox. J Virol (1993) 2.12
CD4+ T cells are required for development of a murine retrovirus-induced immunodeficiency syndrome (MAIDS). J Exp Med (1988) 2.06
Gamma interferon-induced, nitric oxide-mediated inhibition of vaccinia virus replication. J Virol (1995) 1.74
Abrogation of resistance to severe mousepox in C57BL/6 mice infected with LP-BM5 murine leukemia viruses. J Virol (1987) 1.72
Species specificity of ectromelia virus and vaccinia virus interferon-gamma binding proteins. Virology (1995) 1.64
Search for supersymmetry using final states with one lepton, jets, and missing transverse momentum with the ATLAS detector in √s=7 TeV pp collisions. Phys Rev Lett (2011) 1.60
Gene expression and cytopathic effect of vaccinia virus inactivated by psoralen and long-wave UV light. J Virol (1996) 1.58
Nerve injury proximal or distal to the DRG induces similar spinal glial activation and selective cytokine expression but differential behavioral responses to pharmacologic treatment. J Comp Neurol (2001) 1.57
Restricted replication of ectromelia virus in cell culture correlates with mutations in virus-encoded host range gene. Virology (1992) 1.56
A poxvirus-encoded semaphorin induces cytokine production from monocytes and binds to a novel cellular semaphorin receptor, VESPR. Immunity (1998) 1.52
Observation of a centrality-dependent dijet asymmetry in lead-lead collisions at sqrt[S(NN)] =2.76 TeV with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.41
Measurement of dijet azimuthal decorrelations in pp collisions at sqrt(s)=7 TeV. Phys Rev Lett (2011) 1.39
Kinetics of ectromelia virus (mousepox) transmission and clinical response in C57BL/6j, BALB/cByj and AKR/J inbred mice. Lab Anim Sci (1985) 1.38
Direct binding to and tyrosine phosphorylation of the alpha subunit of the type I interferon receptor by p135tyk2 tyrosine kinase. Mol Cell Biol (1994) 1.37
Identification of a novel subunit of the type I interferon receptor localized to human chromosome 21. J Biol Chem (1993) 1.37
Determination of the strange-quark density of the proton from ATLAS measurements of the W→ℓν and Z→ℓℓ cross sections. Phys Rev Lett (2012) 1.34
A third distinct tumor necrosis factor receptor of orthopoxviruses. Proc Natl Acad Sci U S A (1998) 1.34
Search for new particles in two-jet final states in 7 TeV proton-proton collisions with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.32
Potential role of PKR in double-stranded RNA-induced macrophage activation. EMBO J (2000) 1.29
Observation of associated near-side and away-side long-range correlations in sqrt[s(NN)]=5.02 TeV proton-lead collisions with the ATLAS detector. Phys Rev Lett (2013) 1.27
Differences in interferon alpha and beta signaling. Interferon beta selectively induces the interaction of the alpha and betaL subunits of the type I interferon receptor. J Biol Chem (1996) 1.27
A poxvirus protein that binds to and inactivates IL-18, and inhibits NK cell response. J Immunol (2000) 1.25
Inhibition of an inflammatory response is mediated by a 38-kDa protein of cowpox virus. Virology (1989) 1.21
Search for dark matter candidates and large extra dimensions in events with a photon and missing transverse momentum in pp collision data at sqrt[s]=7 TeV with the ATLAS detector. Phys Rev Lett (2013) 1.19
Genetic determinants of resistance to ectromelia (mousepox) virus-induced mortality. J Virol (1985) 1.15
Search for a supersymmetric partner to the top quark in final states with jets and missing transverse momentum at sqrt[s] = 7 TeV with the ATLAS detector. Phys Rev Lett (2012) 1.13
Reexamination of the efficacy of vaccination against mousepox. Lab Anim Sci (1985) 1.13
A poxvirus protein with a RING zinc finger motif is of crucial importance for virulence. Virology (1994) 1.13
Insertional inactivation of the large subunit of ribonucleotide reductase encoded by vaccinia virus is associated with reduced virulence in vivo. Virology (1990) 1.12
Role of lymphokine-secreting CD8+ T cells in cytotoxic T lymphocyte responses against vaccinia virus. J Immunol (1989) 1.12
p135tyk2, an interferon-alpha-activated tyrosine kinase, is physically associated with an interferon-alpha receptor. J Biol Chem (1994) 1.10
Mechanisms of beta-cell death in response to double-stranded (ds) RNA and interferon-gamma: dsRNA-dependent protein kinase apoptosis and nitric oxide-dependent necrosis. Am J Pathol (2001) 1.08
Complementation of the interferon alpha response in resistant cells by expression of the cloned subunit of the interferon alpha receptor. A central role of this subunit in interferon alpha signaling. J Biol Chem (1994) 1.08
Poxvirus-induced alteration of arachidonate metabolism. Proc Natl Acad Sci U S A (1993) 1.07
Search for tb resonances in proton-proton collisions at √s=7 TeV with the ATLAS detector. Phys Rev Lett (2012) 1.07
Search for a light Higgs boson decaying to long-lived weakly interacting particles in proton-proton collisions at sqrt[s] = 7 TeV with the ATLAS detector. Phys Rev Lett (2012) 1.05
Mechanism of host restriction of adenovirus-associated virus replication in African green monkey kidney cells. J Gen Virol (1979) 1.03
Ectromelia virus RING finger protein is localized in virus factories and is required for virus replication in macrophages. J Virol (1995) 1.02
Search for supersymmetry in events with three leptons and missing transverse momentum in √[s]=7 TeV pp collisions with the ATLAS detector. Phys Rev Lett (2012) 0.99
Mousepox outbreak in a laboratory mouse colony. Lab Anim Sci (1996) 0.96
Multigenic evasion of inflammation by poxviruses. J Virol (1994) 0.94
Ligand-independent anti-oncogenic activity of the alpha subunit of the type I interferon receptor. J Biol Chem (1994) 0.92
Variable resistance to ectromelia (mousepox) virus among genera of Mus. Curr Top Microbiol Immunol (1986) 0.91
Acute inflammatory response to cowpox virus infection of the chorioallantoic membrane of the chick embryo. Virology (1992) 0.89
Measurement of the ZZ production cross section and limits on anomalous neutral triple gauge couplings in proton-proton collisions at sqrt[s] = 7 TeV with the ATLAS detector. Phys Rev Lett (2012) 0.86
Inhibition of human immunodeficiency virus type 1 and vaccinia virus infection by a dominant negative factor of the interferon regulatory factor family expressed in monocytic cells. Proc Natl Acad Sci U S A (1996) 0.86
The BALB/c mouse as a model to study orthopoxviruses. Curr Top Microbiol Immunol (1985) 0.86
Analysis of host response modifier ORFs of ectromelia virus, the causative agent of mousepox. Virus Res (2000) 0.86
Stimulation of Stat5 by granulocyte colony-stimulating factor (G-CSF) is modulated by two distinct cytoplasmic regions of the G-CSF receptor. J Immunol (1998) 0.86
Increased susceptibility of mice infected with Schistosoma mansoni to recombinant vaccinia virus: association of viral persistence with egg granuloma formation. Eur J Immunol (1994) 0.85
Search for gluinos in events with two same-sign leptons, jets, and missing transverse momentum with the ATLAS detector in pp collisions at sqrt[s]=7 TeV. Phys Rev Lett (2012) 0.85
In vitro and in vivo study of the ectromelia virus homolog of the vaccinia virus K1L host range gene. Virology (1993) 0.84
Expression of adenovirus E3/19K protein does not alter mouse MHC class I-restricted responses to vaccinia virus. Virology (1994) 0.83
Search for dilepton resonances in pp collisions at √s=7 TeV with the ATLAS detector. Phys Rev Lett (2011) 0.83
Tolerance, opioid-induced allodynia and withdrawal associated allodynia in infant and young rats. Neuroscience (2006) 0.82
Search for new phenomena in tt events with large missing transverse momentum in proton-proton collisions at sqrt[s] = 7 TeV with the ATLAS detector. Phys Rev Lett (2012) 0.82
Inhibitors of the lipoxygenase pathway specifically block orthopoxvirus replication. Virology (1991) 0.82
In vivo murine tumor gene delivery and expression by systemic recombinant vaccinia virus encoding interleukin-1beta. Cancer J Sci Am (2006) 0.82
Selective inhibition of nuclear steroid receptor function by a protein from a human tumorigenic poxvirus. Virology (2000) 0.82
Search for scalar bottom quark pair production with the ATLAS detector in pp collisions at sqrt[s]=7 TeV. Phys Rev Lett (2012) 0.82
Phosphatidylinositol 3-kinase confers resistance to encephalomyocarditis and herpes simplex virus-induced cell death through the activation of distinct downstream effectors. J Immunol (2001) 0.82
Observation of a new χ(b) state in radiative transitions to Υ(1S) and Υ(2S) at ATLAS. Phys Rev Lett (2012) 0.82
Search for production of resonant states in the photon-jet mass distribution using pp collisions at √s=7 TeV collected by the ATLAS detector. Phys Rev Lett (2012) 0.81
Interferon alpha (IFN alpha) signaling in cells expressing the variant form of the type I IFN receptor. J Biol Chem (1994) 0.81
Search for diphoton events with large missing transverse energy in 7 TeV proton-proton collisions with the ATLAS detector. Phys Rev Lett (2011) 0.81
Measurement of Z boson production in Pb-Pb collisions at sqrt[s(NN)]=2.76 TeV with the ATLAS detector. Phys Rev Lett (2013) 0.81
Transmembrane signaling by the alpha subunit of the type I interferon receptor is essential for activation of the JAK kinases and the transcriptional factor ISGF3. J Biol Chem (1995) 0.80
Concanavalin A-stimulated Ca2+ uptake in rat splenocytes. Mol Cell Biochem (1980) 0.80
Evaluation in non-human primates of the safety, immunogenicity and efficacy of recombinant vaccinia viruses expressing the F or G glycoprotein of respiratory syncytial virus. Vaccine (1988) 0.80
Evaluation of an enzyme-linked immunosorbent assay for the detection of ectromelia (mousepox) antibody. J Clin Microbiol (1983) 0.80
Role of converting enzyme in the cardiovascular and adrenal cortical responses to (des-Asp1)-angiotensin I. Proc Soc Exp Biol Med (1976) 0.78
Substance P and multiple sclerosis. Med Hypotheses (1992) 0.78
Identification of a domain in the beta subunit of the type I interferon (IFN) receptor that exhibits a negative regulatory effect in the growth inhibitory action of type I IFNs. J Biol Chem (1998) 0.78
Search for the Higgs boson in the H→WW(*)→ℓ(+)νℓ(-)ν decay channel in pp collisions at √s=7 TeV with the ATLAS detector. Phys Rev Lett (2012) 0.78
Contrasting interactions between phorbol ester and insulin on the regulation of glycogen synthase activity and p33 mRNA accumulation in rat hepatoma cells. Arch Biochem Biophys (1988) 0.77
CD4+ T cells regulate the magnitude of the antibody response to several helper T cell independent antigens. Immunobiology (1991) 0.77
Observations on the replication of ectromelia virus in mouse-derived cell lines: implications for epidemiology of mousepox. Lab Anim Sci (1987) 0.77
Search for direct top squark pair production in final states with one isolated lepton, jets, and missing transverse momentum in sqrt[s] = 7 TeV pp collisions using 4.7 fb(-10 of ATLAS data. Phys Rev Lett (2012) 0.77
Measurement of the azimuthal angle dependence of inclusive jet yields in Pb+Pb collisions at √(sNN)=2.76 TeV with the ATLAS detector. Phys Rev Lett (2013) 0.77
A novel poxvirus gene and its human homolog are similar to an E. coli lysophospholipase. Virus Res (1997) 0.77
Search for pair production of a heavy up-type quark decaying to a W boson and a b quark in the lepton + jets channel with the ATLAS detector. Phys Rev Lett (2012) 0.76
Inhibition of agonist-induced activation of phospholipase C following poxvirus infection. J Biol Chem (1992) 0.76
Measurement of the W+ W- cross section in sqrt(s) = 7 TeV pp collisions with ATLAS. Phys Rev Lett (2011) 0.75
The attenuated NYCBH vaccinia virus deleted for the immune evasion gene, E3L, completely protects mice against heterologous challenge with ectromelia virus. Vaccine (2011) 0.75
Search for pair production of a new b' quark that decays into a Z boson and a bottom quark with the ATLAS detector. Phys Rev Lett (2012) 0.75
Search for the Higgs boson in the H→WW→lνjj decay channel in pp collisions at √s=7 TeV with the ATLAS detector. Phys Rev Lett (2011) 0.75
Search for down-type fourth generation quarks with the ATLAS detector in events with one lepton and hadronically decaying W bosons. Phys Rev Lett (2012) 0.75